In a similar vein, Yuan et al. found that GAS5 indel polymorphisms are associated with enhanced binding of TFAP2A to the promoter region, leading to increased GAS5 expression that is in turn associated with elevated glioma risk [34]. The gene discussed is GAS5; the disease is glioma.